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cedure. The acute BDNF level reductionwas associated
with SBP reduction after 6 months of follow-up.
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The New Japanese Recommendation
for Physical Activity Based on
Dose-Response AnalysisWe read with interest the papers by Lee et al. (1) and
Wen et al. (2), both of which advocated for the health
beneﬁts of low doses of exercise, even performed atmoderate intensity. The American College of Sports
Medicine currently recommends completing the
equivalent of 30 min of moderate-to-vigorous
physical activity (MVPA) per day in bouts of at least
10 min. On the other hand, on the basis of the
results of their exercise dose–response analyses, Lee
et al. (1) and Wen et al. (2) both argue that an
exercise prescription of 5 min of running or 15 min
of walking per day can positively inﬂuence
cardiovascular mortality. The idea is to encourage
people to engage in physical activity (PA), even if
they cannot allocate the recommended daily 30 min.
On the basis of scientiﬁc evidence provided by
the (Japanese) National Institute of Health and Nutri-
tion, the Ministry of Health, Labour and Welfare
established and published the Japanese recommen-
dations for PA (or “ActiveGuide”) in March 2013 (3).
This document advises Japanese adults (i.e., 18 to
64 years of age) to perform 60 min of MVPA
per day without any consideration of the duration
of the bouts. In contrast to the reports of both Lee
et al. (1) and Wen et al. (2), these recommendations
include not only structured bouts of running or
walking, but also incorporate PA resulting from
housework, commuting, or shopping that are over
3 metabolic equivalents (METs). Most importantly,
the main message disseminated to the Japanese
population is “þ10,” representing “þ10 min of MVPA
per day.” To our knowledge, the implementation of
such PA recommendations in a governmental health
promotion policy is a world ﬁrst. It allows the
involvement of people who have already achieved
the targeted 60 min per day and encourages the most
sedentary individuals to become progressively more
active, thus targeting sedentary and more active
people with the same simple message.
The Japanese “þ10” recommendation mainly
results from the 2 following complementary reports.
The ﬁrst is a PA dose–response meta-analysis
completed in March 2011 (4). Data was extracted
from 26 cohort studies that investigated the relation
between the amounts of PA (summed from at least 2
PA domains) and mortality divided by the relative
risk for some noncommunicable diseases (including
cardiovascular diseases, cancer, dementia, and joint
or musculoskeletal diseases). We found that an
increment of 1 MET-h/week, which is equivalent to 2
to 3 min of MVPA per day, results in a 0.8%
reduction of the average relative risk (RR) (see
Table 14 in reference [4]). The second is Japan’s
National Health and Nutrition Survey, completed in
2010, in which the data collected from a sample of
7,876 people indicated that 61% of the Japanese
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10 min per day of PA (5).
Taken together, the results from the meta-analysis
and data of the National Health and Nutrition Survey
provide room for an approximately 3.2% reduction of
the RR (2 to 3 min  4z 10 min, so 0.8%  4z 3.2%),
which is promising from a public health perspective.
To summarize, we demonstrated that a low dose
of >3 METs activities, which can be performed in the
course of daily life, that is, not only structured ses-
sions of running or walking, can positively inﬂuence
the RR for noncommunicable diseases and mortality.
In accordance with the scientiﬁc evidences described
by Lee et al. (1) and Wen et al. (2), the Japanese “þ10”
experience presented here may inspire other public
health agencies, encouraging them to consider an
efﬁcient but engaging low-dose PA message that ﬁts
the characteristics and needs of their populations.
We will be able to validate the effectiveness of such
a policy by comparing PA between 2013 and 2023
using annual objective assessments PA in National
Health and Nutrition Surveys.Haruka Murakami, PhD
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The New Japanese Recommendation for
Physical Activity Based on Dose-Response AnalysisWe would like to thank Dr. Murakami and colleagues
for their interest in our paper (1). Exercise is Medicine
is a global health initiative by the American College
of Sports Medicine to promote and include
physical activity (PA) as a prevention and treatment
option of diseases in all medical care. Knowing the
minimal effective dose of exercise, as a medicine, is
important from both clinical and public health
perspectives. The current aerobic PA guidelines
from the World Health Organization recommend
at least 150 min/week of moderate-intensity or
75 min/week of vigorous-intensity PA, or an
equivalent combination of both (2). Although some
PA is better than none, it still remains uncertain
whether 150 or 75 min/week of moderate- or
vigorous-intensity aerobic exercise is the precise
and effective minimal dose of exercise for health.
In our recent study, a minimum of 30 to 59 min/
week (5 to 10 min/day) of vigorous-intensity running
showed 28% and 58% signiﬁcantly lower risks of
all-cause and cardiovascular mortality, respectively,
compared with the risks associated with no running
(1). On the basis of evidence from the Japanese
National Institute of Health and Nutrition, the
Japanese government recommends goals of 60 min/
day of moderate-to-vigorous PA for adults (18 to 64
years of age) and 40 min/day of moderate-to-
vigorous PA for older adults ($65 years of age).
However, the most important main message is “þ10
min/day of moderate-to-vigorous PA” as a minimal
starting dose of PA for everyone to encourage both
sedentary and active individuals to become
progressively more active (3). This is currently
the lowest speciﬁc dose of PA for health promo-
tion recommended and published by a government
agency.
Current PA guidelines are developed largely on the
basis of observational studies using self-reported
exercise, which are prone to underestimate the true
health beneﬁts of exercise because of over-reporting.
Therefore, the current minimal dose of exercise could
actually be lower than 150 or 75 min/week if it was
accurately reported or objectively measured. In fact,
we found that measured cardiorespiratory ﬁtness, an
objective marker of habitual PA, predicted mortality
better than self-reported PA did (4). Furthermore,
62% of Americans meet the aerobic PA guidelines
based on self-report, however, only 10% meet the
guidelines based on objective accelerometry (5). It is
